for the treatment of chronic cervical discogenic pain (“cCDP”). “Clearance of this IND for BRTX-100 represents a significant milestone and is a testament to the devotion of our talented ...
MELVILLE, N.Y., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback